Jump to content

Pfizer in talks over full license for COVID-19 vaccine in Singapore


Recommended Posts

2021-09-24T074950Z_1_LYNXMPEH8N07K_RTROPTP_4_HEALTH-CORONAVIRUS-SINGAPORE.JPG

FILE PHOTO: A vial of Pfizer-BioNTech vaccine is pictured at Gleneagles hospital's vaccination exercise for healthcare workers, during the coronavirus disease (COVID-19) outbreak, in Singapore January 19, 2021. REUTERS/Edgar Su

 

SINGAPORE (Reuters) - Pfizer Inc is in discussions with Singapore's Health Sciences Authority regarding obtaining a full license application for its COVID-19 vaccine, the company said in response to a query from Reuters.

 

Pfizer-BioNTech's COVID-19 vaccine has interim authorisation under the pandemic special access route in Singapore. The U.S. Food and Drug Administration granted full approval to the vaccine last month.

 

reuters_logo.jpg

-- © Copyright Reuters 2021-09-13
Link to post
Share on other sites

Create an account or sign in to comment

You need to be a member in order to leave a comment

Create an account

Sign up for a new account in our community. It's easy!

Register a new account

Sign in

Already have an account? Sign in here.

Sign In Now
  • Recently Browsing   0 members

    No registered users viewing this page.

×
×
  • Create New...